about
The safety of pharmacologic options for the treatment of persons with hemophilia.Predicting the Uncertain Future of Aptamer-Based Diagnostics and Therapeutics.Safety surveillance in haemophilia and allied disorders.Tailoring hemostatic therapies to lower inhibitor development in previously untreated patients with severe hemophilia A.Immune tolerance induced by platelet-targeted factor VIII gene therapy in hemophilia A mice is CD4 T cell mediated.Novel therapies and current clinical progress in hemophilia A.Non-factor replacement therapy for haemophilia: a current update.
P2860
Q30249200-424C6FCC-2BA8-44D4-8014-E9446A65E192Q38443249-988C489E-7A08-4957-BA20-8B3E79FB51F1Q38784133-A1F9D519-4F8C-49E9-9EEC-3B0B10A2E855Q38828174-CF6D5E89-5E90-4DF3-B622-8A94D299D1F0Q45870660-50D6DCB7-C0EF-4C18-956E-658531A76437Q49745450-9B5ED084-BD13-489F-AB0D-3BA0B08587C7Q52362938-22BC3122-0A66-4B11-A0EF-78FF6FE403BD
P2860
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Novel therapeutic approaches for haemophilia.
@en
type
label
Novel therapeutic approaches for haemophilia.
@en
prefLabel
Novel therapeutic approaches for haemophilia.
@en
P2860
P356
P1433
P1476
Novel therapeutic approaches for haemophilia.
@en
P2093
P2860
P304
P356
10.1111/HAE.12615
P577
2014-12-18T00:00:00Z